Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vision SPF 28 is a broad-spectrum sunscreen formulation that has been utilized in clinical research to evaluate its efficacy in preventing ultraviolet (UV) radiation-induced skin damage. In studies conducted by the Universitair Medisch Centrum Utrecht, it was investigated for its ability to inhibit neutrophil infiltration and the expression of proteolytic enzymes, such as matrix metalloproteinases (MMPs), in the skin following exposure to solar-simulating radiation (SSR). By acting as a physical and chemical barrier against UV radiation, the product aims to prevent acute dermatitis (sunburn), photoaging, and the degradation of the extracellular matrix. The trial context specifically compared the effects of this sunscreen against topical vitamin E and topical betamethasone in healthy adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vision SPF 28.